November 2, 2023
Webinar
Finnegan
Innovators in the pharmaceutical field must conduct clinical trials in order to market their products. These trials often provide the basis for secondary patents that protect innovative aspects of the candidate products, such as preferred formulations, combinations, dosages, new medical uses, etc. In this webinar, we consider the impact of the clinical trials on the patentability of these secondary patents.
Practical discussion will include:
Moderator:
Jamie Barcombe
Presenters:
Maeve O’Flynn
Yieyie Yang, Ph.D.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.